Damora Therapeutics, Inc. is trading at $22.47 (+5.84%) in pre-market sessions with no confirmed company-specific catalyst identified to explain the price action.
- The stock closed at $21.23 on June 18, 2026, prior to the current upward move.
- The gain may be influenced by broader biotech sector sentiment or ongoing analyst interest as no major overnight announcements were reported.
- There are no new earnings updates, regulatory filings, or deal news associated with the company at this time.